AHIP updates mission in bid to rebrand, commits to mental health and chronic care
America’s Health Insurance policy Plans has current its mission and refreshed its brand name in a way it said greater…
AstraZeneca’s Dapagliflozin tablets get DCGI nod for chronic kidney disease
AstraZeneca Pharma India on Saturday mentioned it has received approval from the Medicines Controller Common of India (DCGI) for Dapagliflozin…